The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus
Study Details
Study Description
Brief Summary
Neurofilament Light Chain Protein (NfL) has been found by many studies as a sensitive biomarker of neuronal damage from several reasons, e.g. neurodegenerative diseases (Alzheimer's disease, Multiple Sclerosis, etc.), inflamation (HIV) or trauma. Its role as biomarker thus offers a possibility to predict and manage diseases associated with neuronal damage. Therefore our aim is to investigate the changes in level of NfL in hydrocephalus and to find its role in management of treatment in hydrocephalus.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Study group A Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. |
Diagnostic Test: Lumbar puncture
Standardized lumbar puncture in L3/4 or L4/5 in diagnosis of hydrocephalus and CSF sampling (sample 1 in NfL level measurement)
Diagnostic Test: External lumbar drainage
External lumbar drainage placement for assessing responsivity of external derivation of CSF. It is test of responsivity to ventriculo-peritoneal shunt placement
Diagnostic Test: Lumbar infusion test
Diagnostic test accompanying the first lumbar puncture made as i diagnostic test of hydrocephalus. Based on infusion of saline by 90 mL per hour with measurement of CSF pressure each 1 minute and then count of so-called Rout (index).
Procedure: Ventriculo-peritoneal shunt placement
Surgical procedure based on implantation a thin catheter into brain lateral ventricle (placed through a burrhole from Kocher point) and connection to prechamber and valve (placed behind the ear under skin) and similar thin catheter pushed under skin of neck, chest and abdomen (where put intraperitoneally).
Procedure: General Anesthesia
Standardized combinated general anesthesia with combination of i.v. and inhalated drugs according the protocol. Given by anesthesiologist.
Procedure: Prechamber puncture
Puncture of prechamber (place behind the ear under the skin) by thin needle and aspiration of 5 mL of CSF (5 days, 1 month a 2 months after surgery)
Procedure: Blood sampling #1
Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 24 hours prior surgery
Procedure: Blood sampling #2
Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 24 hours after surgery
Procedure: Blood sampling #3
Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 5 days after surgery
Procedure: Blood sampling #4 and #5
Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 1 and 2 months after surgery (only in interventional group)
|
Active Comparator: Study group B Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia. |
Procedure: General Anesthesia
Standardized combinated general anesthesia with combination of i.v. and inhalated drugs according the protocol. Given by anesthesiologist.
Procedure: Blood sampling #1
Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 24 hours prior surgery
Procedure: Blood sampling #2
Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 24 hours after surgery
Procedure: Blood sampling #3
Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 5 days after surgery
|
Outcome Measures
Primary Outcome Measures
- Recruitment rate [6 months]
To assess the number of patients recruited in a pilot study. Recruitment rate is one of the predictor of feasibility of a study
- Number of changes in valve settings [3 months after surgery]
To investigate the number of changes in valve settings according the patient's clinical state based on clinical examination, CT examination or telemetrically measured CSF pressure
Secondary Outcome Measures
- Correlation between NfL level and patient's clinical state [3 months after surgery]
To investigate in group A the correlation between the level of NfL get from CSF and blood sampling and observation in changes in patient's clinical state measured by mini-mental state examination (MMSE), 5-meter-walking test and patient's self-assessment questionare
Other Outcome Measures
- Influence of general anesthesia on the level of NfL [24 hours before procedure (surgery) and 24 hours and 5 days after surgery]
In group B investigate the level of NfL 24 hours before surgery and 24 hours (blood sampling #2) and 5 days after surgery (blood sampling #3) and comparison with standardized NfL level based on literature. Looking for the influence of general anesthesia on brain damage caused and the prepair in predefined time frame.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
In group A:
-
Patients with diagnosed communicating hydrocephalus
-
MMSE > 10 points
-
Absence of any structural laesion on MRI or CT
-
Accepted Informed consent
-
In group B:
-
MMSE > 10 points
-
Absence of any structural laesion on MRI or CT
-
Accepted Informed consent
-
Elective spinal surgery without affecting dural sac and the spinal cord
-
Surgery shorter than 120 minutes of lasting the general anesthesia
Exclusion Criteria:
-
Non-communicating hydrocephalus
-
Structural laesion on MRI or CT (tumour, contusion, aneurysm)
-
MMSE < 10 points
-
Life-expectancy shorter than 1 year
-
Pre-existing other type of demetia (m. Alzheimer, vascular dementia)
-
Surgery lasting more than 120 minutes
-
Blood loss more than 500 ml
-
Opening of dural sac (liquororhea)
-
Adverse events during general anestesia: MAP<60 mm Hg more than 5 minutes, arythmia with need for farmacological treatment
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University Hospital Hradec Kralove
Investigators
- Principal Investigator: Miroslav Cihlo, M.D., University Hospital Hradec Kralove
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MC00000001